About

Rosetta Capital is a specialist venture capital firm focused on the healthcare and life science sector.

Our team manages and advises more than $130 million of invested and committed capital. Our firm is based in the United Kingdom, and has an active presence in Canada, Germany and Switzerland.

Rosetta was founded in 2001 and brings together a wealth of experience from the venture capital, corporate finance, biotechnology and pharmaceutical sectors.  Our team has backgrounds in medicine, drug discovery, business and corporate development, law and finance, and has been involved in all stages of company development from start-ups emerging from the academic research environment through development stage and public companies.

Rosetta currently has 18 portfolio companies in Europe and North America and is actively seeking new opportunities to invest in individual companies and secondary portfolios.